Vermersch, Patrick

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

Delacourte, A., David, J. P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) · Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 828

Radiologically isolated syndrome: 5-year risk for an initial clinical event

Okuda, D. T., Siva, A., Kantarci, O., Inglese, M., Katz, I., Tutuncu, M., Keegan, B. M., Donlon, S., Hua, L. H., Vidal-Jordana, A., et al. (2014) · PLoS ONE

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 339

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: A phase 2b, randomised, double-blind, placebo-controlled trial

Reich, D. S., Arnold, D. L., Vermersch, P., Bar-Or, A., Fox, R. J., Matta, A., Turner, T., Wallström, E., Zhang, X., Mareš, M., et al. (2021) · The Lancet Neurology

Multiple Sclerosis Research StudiesChronic Lymphocytic Leukemia Research

Cited by 204

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis

Fox, R. J., Bar-Or, A., Traboulsee, A., Oreja-Guevara, C., Giovannoni, G., Vermersch, P., Syed, S., Li, Y., Vargas, W. S., Turner, T. J., et al. (2025) · New England Journal of Medicine

Multiple Sclerosis Research StudiesChronic Lymphocytic Leukemia Research

Cited by 146

Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases

Sergeant, N., David, J.-P., Lefranc, D., Vermersch, P., Wattez, A., & Delacourte, A. (1997) · FEBS Letters

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 117

Inhibition of CD40L with frexalimab in multiple sclerosis

Vermersch, P., Granziera, C., Mao-Draayer, Y., Cutter, G., Kalbus, O., Staikov, I., Dufek, M., Saubadu, S., Bejuit, R., Truffinet, P., et al. (2024) · New England Journal of Medicine

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 102

Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study

Paul, F., Calabresi, P. A., Barkhof, F., Green, A. J., Kardon, R., Sastre‐Garriga, J., Schippling, S., Vermersch, P., Saidha, S., Gerendas, B. S., et al. (2021) · Annals of Clinical and Translational Neurology

Multiple Sclerosis Research StudiesGlaucoma and retinal disorders

Cited by 98

Quality of life in multiple sclerosis: influence of interferon-β1a (Avonex®) treatment

Vermersch, P., de Seze, J., Delisse, B., Lemaire, S., & Stojkovic, T. (2002) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of Life

Cited by 74

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients

Ayrignac, X., Carra-Dalliere, C., Menjot de Champfleur, N., Denier, C., Aubourg, P., Bellesme, C., Castelnovo, G., Pelletier, J., Audoin, B., Kaphan, E., et al. (2015) · Brain

Cerebrovascular and genetic disordersMetabolism and Genetic Disorders

Cited by 74

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial

Vermersch, P., Brieva-Ruiz, L., Fox, R. J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O., Maciejowski, M., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 74

Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease

Lefranc, D., Vermersch, P., Dallongeville, J., Daems-Monpeurt, C., Petit, H., & Delacourte, A. (1996) · Neuroscience Letters

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 47

Brain MRI in late‐onset multiple sclerosis

de Seze, J., Delalande, S., Michelin, E., Gauvrit, J. Y., Mackowiak, M. A., Ferriby, D., Stojkovic, T., Defebvre, L., Pruvo, J. P., & Vermersch, P. (2005) · European Journal of Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 31

The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors

Vermersch, P., Airas, L., Berger, T., Deisenhammer, F., Grigoriadis, N., Hartung, H.-P., Magyari, M., Popescu, V., Pozzilli, C., Pugliatti, M., et al. (2025) · Frontiers in Immunology

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 21

Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores

Lin, T.-Y., Motamedi, S., Asseyer, S., Chien, C., Saidha, S., Calabresi, P. A., Fitzgerald, K. C., Samadzadeh, S., Villoslada, P., Llufriu, S., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation

Multiple Sclerosis Research StudiesGlaucoma and retinal disorders

Cited by 12

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Dubois, B., López‑Arrieta, J., Lipschitz, S., Doskas, T., Spiru, L., Moroz, S., Venger, O., Vermersch, P., Moussy, A., Mansfield, C. D., et al. (2023) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 10